These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32244310)

  • 1. External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients.
    van Kleef JJ; van den Boorn HG; Verhoeven RHA; Vanschoenbeek K; Abu-Hanna A; Zwinderman AH; Sprangers MAG; van Oijen MGH; De Schutter H; van Laarhoven HWM
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32244310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.
    van den Boorn HG; Abu-Hanna A; Ter Veer E; van Kleef JJ; Lordick F; Stahl M; Ajani JA; Guimbaud R; Park SH; Dutton SJ; Bang YJ; Boku N; Mohammad NH; Sprangers MAG; Verhoeven RHA; Zwinderman AH; van Oijen MGH; van Laarhoven HWM
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
    Kuijper SC; Pape M; Haj Mohammad N; van Voorthuizen T; Verhoeven RHA; van Laarhoven HWM
    Int J Cancer; 2023 Mar; 152(6):1202-1209. PubMed ID: 36451334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a novel risk prediction algorithm to estimate 10-year risk of oesophageal cancer in primary care: prospective cohort study and evaluation of performance against two other risk prediction models.
    Hippisley-Cox J; Mei W; Fitzgerald R; Coupland C
    Lancet Reg Health Eur; 2023 Sep; 32():100700. PubMed ID: 37635924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.
    van den Boorn HG; Abu-Hanna A; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Klarenbeek BR; Slingerland M; Beerepoot LV; Rozema T; Sprangers MAG; Verhoeven RHA; van Oijen MGH; Zwinderman KH; van Laarhoven HWM
    J Natl Compr Canc Netw; 2021 Apr; 19(4):403-410. PubMed ID: 33636694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry.
    Brenkman HJF; Cho M; Ruurda JP; Song K; Son T; Kim HI; Noh SH; van Hillegersberg R; Hyung WJ
    Eur J Surg Oncol; 2019 Jun; 45(6):983-988. PubMed ID: 30654921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of a prognostic model incorporating quantitative PET image features in oesophageal cancer.
    Foley KG; Shi Z; Whybra P; Kalendralis P; Larue R; Berbee M; Sosef MN; Parkinson C; Staffurth J; Crosby TDL; Roberts SA; Dekker A; Wee L; Spezi E
    Radiother Oncol; 2019 Apr; 133():205-212. PubMed ID: 30424894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Maekawa Y; Fukuda K; Cohen DJ; Kennedy KF; Rumsfeld JS; Spertus JA
    J Am Coll Cardiol; 2016 Apr; 67(14):1715-22. PubMed ID: 27056778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
    Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
    JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the SORG 90-day and 1-year machine learning algorithms for survival in spinal metastatic disease.
    Karhade AV; Ahmed AK; Pennington Z; Chara A; Schilling A; Thio QCBS; Ogink PT; Sciubba DM; Schwab JH
    Spine J; 2020 Jan; 20(1):14-21. PubMed ID: 31505303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Model for Gastric Cancer Incidence in Korean Population.
    Eom BW; Joo J; Kim S; Shin A; Yang HR; Park J; Choi IJ; Kim YW; Kim J; Nam BH
    PLoS One; 2015; 10(7):e0132613. PubMed ID: 26186332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognosis prediction model after completion gastrectomy for remnant gastric cancer: Development and validation using international multicenter databases.
    Lu J; Zheng ZF; Zhou JF; Xu BB; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Truty MJ; He QL; Huang CM
    Surgery; 2019 Sep; 166(3):314-321. PubMed ID: 31221436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
    Collins GS; Altman DG
    Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases.
    Woo Y; Son T; Song K; Okumura N; Hu Y; Cho GS; Kim JW; Choi SH; Noh SH; Hyung WJ
    Ann Surg; 2016 Jul; 264(1):114-20. PubMed ID: 26945155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
    Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
    J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer.
    Thomas M; Defraene G; Lambrecht M; Deng W; Moons J; Nafteux P; Lin SH; Haustermans K
    Radiother Oncol; 2019 Dec; 141():33-40. PubMed ID: 31630867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer.
    Kim JH; Kim HS; Seo WY; Nam CM; Kim KY; Jeung HC; Lai JF; Chung HC; Noh SH; Rha SY
    Ann Oncol; 2012 Feb; 23(2):361-7. PubMed ID: 21566150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.